Article in Science translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
25 authors.
Orlee Marini-RapoportCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA 02124, USA.ORCID 0009-0000-0788-3406
Léna AndrieuxCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA 02124, USA.ORCID 0009-0005-7664-0527
Tarun KeswaniCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA 02124, USA.ORCID 0000-0002-0307-692X
Guangning ZongNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.ORCID 0000-0001-6019-5741
Dylan DuchenDepartment of Pathology, Yale School of Medicine, New Haven, CT 06510, USA.ORCID 0000-0001-5629-2012
Gur YaariDepartment of Pathology, Yale School of Medicine, New Haven, CT 06510, USA.ORCID 0000-0001-9311-9884
Jungki MinNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.ORCID 0000-0003-1860-3064
Isabelle R LytleNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.ORCID 0000-0003-3501-3904
Alexander F RosenbergDepartment of Biomedical Informatics and Data Science, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Christopher FucileDepartment of Biomedical Informatics and Data Science, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
James J KobieDivision of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-8069-0272
Michael S PiepenbrinkDivision of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-7517-6412
Timothy SunDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Massachusetts General Hospital, Boston, MA 02124, USA.
Victoria M MartinFood Allergy Center, Massachusetts General Hospital, Boston, MA 02124, USA.ORCID 0000-0002-4322-9564
Qian YuanFood Allergy Center, Massachusetts General Hospital, Boston, MA 02124, USA.
Wayne G ShrefflerCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA 02124, USA.ORCID 0000-0001-6465-137X
Antti E SeppoPediatric Allergy and Immunology, Department of Food Allergy, University of Rochester School of Medicine, Rochester, NY 14642, USA.ORCID 0000-0001-5757-5268
Kirsi M JärvinenPediatric Allergy and Immunology, Department of Food Allergy, University of Rochester School of Medicine, Rochester, NY 14642, USA.ORCID 0000-0003-1548-6712
Johannes R LoefflerDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-5724-655X
Andrew B WardDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0001-7153-3769
Steven H KleinsteinDepartment of Pathology, Yale School of Medicine, New Haven, CT 06510, USA.ORCID 0000-0003-4957-1544
Lars C PedersenNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.ORCID 0000-0002-4488-4077
Monica L Fernández-QuinteroDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-6811-6283
Geoffrey A MuellerNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.ORCID 0000-0001-8361-5323
Sarita U PatilCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA 02124, USA.ORCID 0000-0002-2172-2286
Funding
X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Martin Fuchs · 2019 to 2026
$38.6M
Crystallographic studies of macromolecular structuresZICES102645 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI PEDERSEN, LARS · 2018 to 2025
$12.6M
Structural and Functional Characterization of AllergensZIAES102906 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MUELLER, GEOFFREY · 2010 to 2025
$10.0M
COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTSR01AI104739 · NIAID · YALE UNIVERSITY · PI KLEINSTEIN, STEVEN H. · 2014 to 2022
$3.6M
Structural and functional characterization of protective antibodies induced in peanut oral immunotherapyR01AI155630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Sarita U Patil · 2021 to 2026
$3.1M
Convergent allergen-specific antibodies in food allergyR01AI182001 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Sarita U Patil · 2024 to 2026
$2.5M
Systems approach to elucidate the microbiome's influence on the development of food allergies early in lifeK23AI151556 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARTIN, VICTORIA MACKENZIE · 2021 to 2025
Humans develop immunoglobulin G (IgG) antibodies to the foods they consume. In the context of food allergy, allergen-specific IgG antibodies can sequentially class-switch to pathogenic IgE. However, the mechanism underlying the antigenicity of food proteins remains uncharacterized. Here, we identified convergent antibodies arising from different antibody gene rearrangements that bind to the immunodominant peanut allergen Ara h 2 and characterized allelic and junctional constraints on germline antibody specificity. Structurally, we found similar epitope-paratope interactions across multiple gene rearrangements. We demonstrate that these germline-encoded epitope-specific convergent antibodies to peanut occur commonly in the population because of the worldwide prevalence of the relevant gene rearrangements, allelic independence, and junctional malleability. As a result, serum IgG to this public epitope is prevalent among diverse cohorts of nonallergic peanut-consuming infants and peanut-allergic children and adults. This work demonstrates that IgG recognition of dietary antigens can be intrinsically programmed by the germline antibody repertoire.
Indexed as
ArachisGerm Cells2S Albumins, PlantAdultAntigens, PlantChildEpitopesHumansImmunoglobulin GInfantPeanut Hypersensitivity2S Albumins, PlantAntigens, PlantAra h 2 allergen, Arachis hypogaeaEpitopesImmunoglobulin G
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans. · full record | OpenQuestion